Last week, Choosing Wisely released a list of 45 overused tests and treatments as determined by nine major medical societies.
Last week, Choosing Wisely, an initiative of the ABIM Foundation that promotes evidenced-based medicine, released a list of 45 overused tests and treatments as determined by nine major medical societies. No ob/gyn associations were included in the list, but two recommendations are applicable to gynecologists:
From the American Academy of Family Physicians and consistent with ACOG’s guidelines:
Don’t perform Pap smears on women younger than 21 or who have had a hysterectomy for non-cancer disease.
Most observed abnormalities in adolescents regress spontaneously, therefore Pap smears for this age group can lead to unnecessary anxiety, additional testing and cost. Pap smears are not helpful in women after hysterectomy (for non-cancer disease) and there is little evidence for improved outcomes.
From the American College of Radiology:
Don’t recommend follow-up imaging for clinically inconsequential adnexal cysts.
Simple cysts and hemorrhagic cysts in women of reproductive age are almost always physiologic. Small simple cysts in postmenopausal women are common, and clinically inconsequential. Ovarian cancer, while typically cystic, does not arise from these benign-appearing cysts. After a good quality ultrasound in women of reproductive age, don’t recommend follow-up for a classic corpus luteum or simple cyst <5 cm in greatest diameter. Use 1 cm as a threshold for simple cysts in postmenopausal women.
Do you agree, and do you adhere to these recommendations in your practice? Are there other ob/gyn tests that should be on this list?
SKYLIGHT trials confirm safety and efficacy of fezolinetant against sleep disturbances
September 13th 2024At the 2024 Annual Meeting of The Menopause Society, the positive safety and efficacy data of fezolinetant against sleep disturbances from the SKYLIGHT 1 and 2 trials was presented.
Read More
Study shows hormone therapy offers lasting benefits for women over 65
September 12th 2024A new study presented at the 2024 Annual Meeting of The Menopause Society shows hormone therapy remains beneficial for women over 65, helping manage menopause symptoms like hot flashes and improving quality of life.
Read More